These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32877293)

  • 21. Identification and characterization of a long non-coding RNA up-regulated during HIV-1 infection.
    Postler TS; Pantry SN; Desrosiers RC; Ghosh S
    Virology; 2017 Nov; 511():30-39. PubMed ID: 28803142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential regulation of CXCR4 and CCR5 expression by interleukin (IL)-4 and IL-13 is associated with inhibition of chemotaxis and human immunodeficiency Virus (HIV) type 1 replication but not HIV entry into human monocytes.
    Creery D; Weiss W; Graziani-Bowering G; Kumar R; Aziz Z; Angel JB; Kumar A
    Viral Immunol; 2006; 19(3):409-23. PubMed ID: 16987060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The emerging role of long non-coding RNAs in HIV infection.
    Lazar DC; Morris KV; Saayman SM
    Virus Res; 2016 Jan; 212():114-26. PubMed ID: 26221763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic influence of CCR5, CCR2, and SDF1 variants on human immunodeficiency virus 1 (HIV-1)-related disease progression and neurological impairment, in children with symptomatic HIV-1 infection.
    Singh KK; Barroga CF; Hughes MD; Chen J; Raskino C; McKinney RE; Spector SA
    J Infect Dis; 2003 Nov; 188(10):1461-72. PubMed ID: 14624371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Up-regulation of HIV coreceptors CXCR4 and CCR5 on CD4(+) T cells during human endotoxemia and after stimulation with (myco)bacterial antigens: the role of cytokines.
    Juffermans NP; Paxton WA; Dekkers PE; Verbon A; de Jonge E; Speelman P; van Deventer SJ; van der Poll T
    Blood; 2000 Oct; 96(8):2649-54. PubMed ID: 11023494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CCR5 promoter polymorphism determines macrophage CCR5 density and magnitude of HIV-1 propagation in vitro.
    Salkowitz JR; Bruse SE; Meyerson H; Valdez H; Mosier DE; Harding CV; Zimmerman PA; Lederman MM
    Clin Immunol; 2003 Sep; 108(3):234-40. PubMed ID: 14499246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The HIV type 1 coreceptor CCR5 and its role in viral transmission and disease progression.
    Paxton WA; Kang S; Koup RA
    AIDS Res Hum Retroviruses; 1998 Apr; 14 Suppl 1():S89-92. PubMed ID: 9581891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. R5 human immunodeficiency virus type 1 infection of fetal thymic organ culture induces cytokine and CCR5 expression.
    Choudhary SK; Choudhary NR; Kimbrell KC; Colasanti J; Ziogas A; Kwa D; Schuitemaker H; Camerini D
    J Virol; 2005 Jan; 79(1):458-71. PubMed ID: 15596839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Establishment of mouse leukemia cell lines expressing human CD4/CCR5 using lentiviral vectors.
    Li YJ; ZhuGe FY; Zeng CC; He JY; Tan N; Liang J
    Virus Genes; 2017 Apr; 53(2):197-204. PubMed ID: 28028680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CCR5-targeted hematopoietic stem cell gene approaches for HIV disease: current progress and future prospects.
    Lai Y
    Curr Stem Cell Res Ther; 2012 Jul; 7(4):310-7. PubMed ID: 22486585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. YY1 transcription factor down-regulates expression of CCR5, a major coreceptor for HIV-1.
    Moriuchi M; Moriuchi H
    J Biol Chem; 2003 Apr; 278(15):13003-7. PubMed ID: 12571248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multivalent anti-CCR ribozymes for stem cell-based HIV type 1 gene therapy.
    Bai J; Rossi J; Akkina R
    AIDS Res Hum Retroviruses; 2001 Mar; 17(5):385-99. PubMed ID: 11282007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of Delta 32-CCR5 heterozygosity on HIV-1 genetic evolution and variability--a study of 4 individuals infected with closely related HIV-1 strains.
    Chalmet K; Van Wanzeele F; Demecheleer E; Dauwe K; Pelgrom J; Van Der Gucht B; Vogelaers D; Plum J; Stuyver L; Vandekerckhove L; Verhofstede C
    Virology; 2008 Sep; 379(2):213-22. PubMed ID: 18692212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The efficiency of R5 HIV-1 infection is determined by CD4 T-cell surface CCR5 density through G alpha i-protein signalling.
    Lin YL; Mettling C; Portalès P; Réant B; Robert-Hebmann V; Reynes J; Clot J; Corbeau P
    AIDS; 2006 Jun; 20(10):1369-77. PubMed ID: 16791011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of a third CCR5 amplicon from CCR5-delta32-heterozygous HIV-1-infected individuals.
    Aikhionbare FO; Newman C; Womack C; Roth WW; Stringer HG; Bond VC
    AIDS; 1999 Aug; 13(12):1585-6. PubMed ID: 10465086
    [No Abstract]   [Full Text] [Related]  

  • 36. CCR5 Revisited: How Mechanisms of HIV Entry Govern AIDS Pathogenesis.
    Brelot A; Chakrabarti LA
    J Mol Biol; 2018 Aug; 430(17):2557-2589. PubMed ID: 29932942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CCR5-Δ32 Heterozygosity, HIV-1 Reservoir Size, and Lymphocyte Activation in Individuals Receiving Long-term Suppressive Antiretroviral Therapy.
    Henrich TJ; Hanhauser E; Harrison LJ; Palmer CD; Romero-Tejeda M; Jost S; Bosch RJ; Kuritzkes DR
    J Infect Dis; 2016 Mar; 213(5):766-70. PubMed ID: 26512140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential Ability of Primary HIV-1 Nef Isolates To Downregulate HIV-1 Entry Receptors.
    Toyoda M; Ogata Y; Mahiti M; Maeda Y; Kuang XT; Miura T; Jessen H; Walker BD; Brockman MA; Brumme ZL; Ueno T
    J Virol; 2015 Sep; 89(18):9639-52. PubMed ID: 26178998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemokine coreceptor usage by diverse primary isolates of human immunodeficiency virus type 1.
    Zhang L; He T; Huang Y; Chen Z; Guo Y; Wu S; Kunstman KJ; Brown RC; Phair JP; Neumann AU; Ho DD; Wolinsky SM
    J Virol; 1998 Nov; 72(11):9307-12. PubMed ID: 9765480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data.
    Ioannidis JP; Rosenberg PS; Goedert JJ; Ashton LJ; Benfield TL; Buchbinder SP; Coutinho RA; Eugen-Olsen J; Gallart T; Katzenstein TL; Kostrikis LG; Kuipers H; Louie LG; Mallal SA; Margolick JB; Martinez OP; Meyer L; Michael NL; Operskalski E; Pantaleo G; Rizzardi GP; Schuitemaker H; Sheppard HW; Stewart GJ; Theodorou ID; Ullum H; Vicenzi E; Vlahov D; Wilkinson D; Workman C; Zagury JF; O'Brien TR;
    Ann Intern Med; 2001 Nov; 135(9):782-95. PubMed ID: 11694103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.